Vivera Pharmaceuticals Names Dr. Jon Norman Chief Scientific Officer

Newport Beach, California–(Newsfile Corp. – June 4, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Jon Norman, Ph.D., as the Company’s Chief Scientific Officer. Key aspects of his role include creating clinical trial protocols that support the FDA’s New Drug Application (NDA) process, as well as collaborating with Contract Research Organizations (CROs) to implement clinical trials and case studies. He is currently designing the Company’s case studies on opiate cessation and deterrence.

“Attitudes are quickly changing around the use of cannabidiol (CBD)-based therapies as effective alternatives for pain management, and the data we are seeing supports that,” said Dr. Norman. “As protocols evolve with guidance from the FDA, it is important to determine and implement the precise sequence for successful and compliant product development and

... read more at: https://finance.yahoo.com/news/vivera-pharmaceuticals-names-dr-jon-131500240.html

Leave a Reply